Special Report in 2002

While industrial agrobiotech R&D falters, opportunities in plant biology in the public sector are growing, says Virginia Gewin.

Will the malaria genome open the door to new drugs, vaccines and job opportunities? Di Gershon investigates

Pacific Rim countries are vying to recruit scientists, but they face some stiff obstacles, says Robert Triendl.

The biotech scene, although volatile, will continue to provide jobs. But potential employees should prepare for a bumpy ride, say Paul Smaglik and Adam Smith.

Around the world, universities are starting to encourage entrepreneurship among science students. Steve Bunk investigates.

Every year, thousands of researchers head for the US National Institutes of Health. But what draws them there? Karen Kreeger finds out.

Funding increases for biodefence research in the United States will have a sizable impact on the landscape for jobs, says Eugene Russo.

Several programmes are giving scientists a taste of politics — and aiding a transition into policy careers. Eugene Russo conducts a briefing.

Will toxicogenomics turn toxicology into a predictive and preventive science? Diane Gershon looks at the plans for the future.